Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2000, p. 1444-1448, Vol. 38, No. 4
Department of Pathology, Hershey Medical
Center, Hershey, Pennsylvania 17033,1 and
Department of Pathology, Case Western Reserve
University, Cleveland, Ohio 441062
Received 13 October 1999/Returned for modification 26 November
1999/Accepted 3 January 2000
Agar dilution and microdilution (both in air) and E test and disk
diffusion (both in air and CO2) were used to test the
activity of telithromycin against 110 erythromycin-susceptible and 106 erythromycin-resistant pneumococci. The MICs at which 50 and 90% of
strains are inhibited (MIC50s and MIC90s,
respectively) for erythromycin-susceptible strains varied between 0.008 and 0.016 µg/ml and 0.016 and 0.03 µg/ml when the samples were
incubated in air. By comparison, telithromycin MIC50s and
MIC90s for erythromycin-resistant strains were in air 0.03 to 0.125 and 0.125 to 0.5 µg/ml, respectively. When agar dilution was
used as the reference method, essential agreement was found for 112 of
216 strains (51.9%) for microdilution, 168 of 216 (77.8%) for E test
in air, and 132 of 216 (61.1%) for E test in CO2. With the
exception of four strains tested by E test in CO2, all
organisms were susceptible to a proposed telithromycin susceptibility
breakpoint of
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Antipneumococcal Activity of Telithromycin by Agar
Dilution, Microdilution, E Test, and Disk Diffusion
Methodologies
1 µg/ml. By disk diffusion with 15-µg telithromycin
disks, all strains but one had zones of inhibition
19 mm in diameter
when incubated in CO2, while all strains had zone diameters
of
22 mm when incubated in air. Zone diameters in air were generally
4 to 5 mm larger than in CO2. By all methods, MICs and
zones of all erythromycin-resistant strains occurred in clusters
separated from those seen with erythromycin-susceptible strains. The
results for macrolide-resistant strains with erm and
mef resistance determinants were similar. The results show that (i) telithromycin is very active against erythromycin-susceptible and -resistant strains irrespective of macrolide resistance mechanism; (ii) susceptibility to telithromycin can be reliably tested by the
agar, microdilution, E test, and disk diffusion methods; and (iii)
incubation in CO2 led to smaller zones by disk diffusion and higher MICs by E test, but at a susceptible MIC breakpoint of
1
µg/ml and a susceptible zone diameter cutoff of
19 mm in CO2, 215 of 216 strains were found to be susceptible to telithromycin.
*
Corresponding author. Mailing address: Department of
Pathology, Hershey Medical Center, 500 University Dr., Hershey, PA
17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail:
pappelbaum{at}psghs.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|